Solutions to Optimize Cell Therapy Development and Manufacturing

Published on: 

Catalent's Martin De Brauwere and Maria Lopez react to cell therapy innovations and highlight strategies to optimize the drug development and manufacturing process with assistance from a CDMO.

LEARN MORE IN THIS VIDEO:

- Current state of the cellular therapy market and challenges bringing newer therapies to commercialization

- Critical components tied to successful drug development and manufacturing of cell therapies

- Remaining current with regulatory guidance tied to cell therapies

- Proper oversight of supply chains tied to a cell therapy project